Arvind Ravi MD, PhDMedical Oncologist, Dana-Farber Cancer Institute, Boston, Massachusetts
Dr. Arvind Ravi is a medical oncologist at Dana-Farber Cancer Institute in Boston. He completed his medical training in the joint Harvard-MIT HST program, during which he obtained a PhD in Biology from MIT. After graduation, he completed residency training in internal medicine at Brigham and Women’s Hospital, followed by a medical oncology fellowship in the combined Dana-Farber/Massachusetts General Hospital training program.
He is a recipient of a 2019 ASCO Foundation Conquer Cancer Young Investigator Award as well as an NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers. His current research aims to understand the molecular underpinnings of intrinsic and acquired resistance in advanced cancers.
He is a member of the American Society of Clinical Oncology and the American Association of Cancer Research among other organizations.
DisclosuresDr. Ravi reports the following: advisory/consulting: Tyra, Halo, AccessHope.